Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA

Transfusion

Volumn 57, Issue 3, 2017, Pages 734-747

  Stone, Mars ^a   Lanteri, Marion C ^a,b   Bakkour, Sonia ^a   Deng, Xutao ^a   Galel, Susan A ^c   Linnen, Jeffrey M ^d   Muñoz Jordán, Jorge L ^e   Lanciotti, Robert S ^e   Rios, Maria ^f   Gallian, Pierre ^g   Musso, Didier ^h   Levi, José E ⁱ   Sabino, Ester C ^j   Coffey, Lark L ^k   Busch, Michael P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d HOLOGIC INC   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g Aix Marseille University IRD 190 Inserm 1207   (France)

^h Institut Louis Malarde   (France)

ⁱ FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BRAZILIAN; CONTROLLED STUDY; DILUTION; FRENCH POLYNESIA; LIMIT OF DETECTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SENSITIVITY ANALYSIS; VIRUS ISOLATION; ZIKA VIRUS; ADULT; BLOOD; DONOR SELECTION; FEMALE; HUMAN; MALE; PROCEDURES; ZIKA VIRUS INFECTION;

ADULT; BLOOD DONORS; DONOR SELECTION; FEMALE; HUMANS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85013078226     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14031     Document Type: Article

References (52)

1. Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev 2016;29:487-524.
2. Richard V, Paoaafaite T, Cao-Lormeau VM. Vector competence of French Polynesian Aedes aegypti and Aedes polynesiensis for Zika Virus. PLoS Negl Trop Dis 2016;10:e0005024
3. Oliveira Melo AS, Malinger G, Ximenes R, et al. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016;47:6-7.
4. Sarno M, Sacramento GA, Khouri R, et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl Trop Dis 2016;10:e0004517
5. Besnard M, Lastere S, Teissier A, Cao-Lormeau V, Musso D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014;19. pii: 20551
6. Davidson A, Slavinski S, Komoto K, et al. Suspected female-to-male sexual transmission of Zika Virus - New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65:716-7.
7. Deckard DT, Chung WM, Brooks JT, et al. Male-to-male sexual transmission of Zika Virus—Texas, January 2016. MMWR Morb Mortal Wkly Rep 2016;65:372-4.
8. Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011;17:880-2.
9. Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015;21:359-61.
10. Barjas-Castro ML, Angerami RN, Cunha MS, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016;56:1684-8.
11. Motta IJ, Spencer BR, Cordeiro da Silva SG, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med 2016;375:1101-3.
12. Bingham AM, Cone M, Mock V, et al. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease—Florida, 2016. MMWR Morb Mortal Wkly Rep 2016;65:475-8.
13. Bonaldo MC, Ribeiro IP, Lima NS, et al. Isolation of infective Zika virus from urine and saliva of patients in Brazil. PLoS Negl Trop Dis 2016;10:e0004816.
14. Campos Rde M, Cirne-Santos C, Meira GL, et al. Prolonged detection of Zika virus RNA in urine samples during the ongoing Zika virus epidemic in Brazil. J Clin Virol 2016;77:69-70.
15. Gourinat AC, O'Connor O, Calvez E, et al. Detection of Zika virus in urine. Emerg Infect Dis 2015;21:84-6.
16. Jayakumar P, Brar K, Lippmann S. Best Zika virus detection: saliva, serum, or urine? South Med J 2016;109:697.
17. Zhang FC, Li XF, Deng YQ, et al. Excretion of infectious Zika virus in urine. Lancet Infect Dis 2016;16:641-2.
18. Musso D, Roche C, Nhan TX, et al. Detection of Zika virus in saliva. J Clin Virol 2015;68:53-5.
19. Atkinson B, Hearn P, Afrough B, et al. Detection of Zika virus in semen [letter]. Emerg Infect Dis 2016;22:490.
20. Brasil P, Nielsen-Saines K. More pieces to the microcephaly-Zika virus puzzle in Brazil. Lancet Infect Dis 2016;16:1307-9.
21. Brasil P, Pereira JP Jr, Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med 2016;375:2321-4.
22. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med 2016;374:951-8.
23. Nunes ML, Carlini CR, Marinowic D, et al. Microcephaly and Zika virus: a clinical and epidemiological analysis of the current outbreak in Brazil. J Pediatr (Rio J) 2016;92:230-40.
24. Wang JN, Ling F. Zika virus infection and microcephaly: evidence for a causal link. Int J Environ Res Public Health 2016;13. pii: E1031.
25. Centers for Disease Control and Prevention (CDC). Case counts in the US [monograph on the internet] [cited December 31, 2016]. Atlanta (GA): CDC; 2016. Available from: https://www.cdc.gov/zika/geo/united-states.html
26. Centers for Disease Control and Prevention (CDC). Pregnancy outcomes in the United States and the District of Columbia [monograph on the internet] [cited December 31, 2016]. Atlanta (GA): CDC; 2016. Available from: https://www.cdc.gov/zika/geo/pregnancy-outcomes.html
27. Fleming-Dutra KE, Nelson JM, Fischer M, et al. Update: interim guidelines for health care providers caring for infants and children with possible Zika virus infection—United States, February 2016. MMWR Morb Mortal Wkly Rep 2016;65:182.
28. Oduyebo T, Petersen EE, Rasmussen SA, et al. Update: interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure—United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:122-7.
29. Staples JE, Dziuban EJ, Fischer M, et al. Interim guidelines for the evaluation and testing of infants with possible congenital Zika Virus infection—United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:63-7.
30. Petersen EE, Staples JE, Meaney-Delman D, et al. Interim guidelines for pregnant women during a Zika virus outbreak—United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:30-3.
31. Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014;19. pii: 20761.
32. US Food and Drug Administration (FDA). Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus—guidance for industry. Silver Spring (MD): US Department of Health and Human Services, FDA, Center for Biologics Evaluaton and Research; 2016.
33. European Center for Disease Prevention and Control (ECDC). Zika virus and safety of substances of human origin. Stockholm (Sweden): ECDC; 2016.
34. World Health Organization (WHO). Maintaining a safe and adequate blood supply during Zika virus outbreaks. Geneva (Switzerland): WHO Press; 2016.
35. Musso D, Stramer SL; AABB Transfusion-Transmitted Diseases Committee, et al. Zika virus: a new challenge for blood transfusion. Lancet 2016;387:1993-4.
36. Lanteri MC, Kleinman SH, Glynn SA, et al. Zika virus: a new threat to the safety of the blood supply with worldwide impact and implications. Transfusion 2016;56:1907-14.
37. US Food and Drug Administraton (FDA). Emergency use authorizations [cited December 31, 2016]. Silver Spring (MD): US Department of Health and Human Services, FDA, Center for Biologics Evaluation and Research; 2016. Available from: http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm
38. Baronti C, Piorkowski G, Charrel RN, Boubis L, Leparc-Goffart I, de Lamballerie X. Complete coding sequence of Zika virus from a French Polynesia outbreak in 2013. Genome Announc 2014;2. pii: e00500-14
39. Trösemeier JH, Musso D, Blümel J, Thézée J, Pybus OG, Baylis SA. Genome sequence of a candidate World Health Organization reference strain of Zika virus for nucleic acid testing. Genome Announc 2016;4. pii: e000917-16.
40. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232-9.
41. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014;20:O595-6.
42. Musso D. Zika Virus transmission from French Polynesia to Brazil. Emerg Infect Dis 2015;21:1887.
43. Centers for Disease Control and Preventon (CDC). Areas with Zika [monograph on the internet] [cited December 31, 2016]. Atlanta (GA): CDC; 2016. Available from: https://www.cdc.gov/zika/geo/
44. European Center for Disease Prevention and Control (ECDC). Rapid risk assessment: Zika virus infection outbreak, French Polynesia. 14 February 2014. Stockholm (Sweden): ECDC; 2014.
45. Gulland A. Zika virus is a global public health emergency, declares WHO. BMJ 2016;352:i657.
46. Cunha MS, Esposito DL, Rocco IM, et al. First complete genome sequence of Zika virus (Flaviviridae, Flavivirus) from an autochthonous transmission in Brazil. Genome Announc 2016;4. pii: e000032-16.
47. World Health Organizationo (WHO). Maintaining a safe and adequate blood supply during Zika virus outbreaks—Interim guidance. Geneva (Switzerland): WHO Press; 2016.
48. US Food and Drug Administration (FDA). Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components. Guidance for industry. Silver Spring (MD): US Department of Health and Human Services, FDA, Center for Biologics Evaluation and Research; 2016.
49. Aubry M, Richard V, Green J, Brolt J, Musso D. Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 2016;56:33-40.
50. Weiner E, Velez E, Alsina J, Chrebtow V, Bunch C. Implementation of the INTERCEPT Blood System for platelets in Puerto Rico to help safeguard against Zika. Presented at: 2016 AABB Annual Meeting; October 22-25, 2016; Orlando, FL.
51. Galel S, Williamson P, Busch M, et al. First Zika positive donations in the continental United States. Transfusion 2016;57:0.
52. Williamson P, Linnen J, Kessler D, et al. First cases of Zika virus infected US blood donors outside states with areas of active transmission. Transfusion 2016;57:0.